Varian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation | Varian

{ "pageType": "news-article", "title": "Varian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation", "articleDate": "2017年 6月 20日", "introText": "", "category": "Corporate and Financial Releases" }

Varian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation

PALO ALTO, Calif., June 20, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced it has successfully installed a Varian ProBeam cyclotron at the National Centre for Particle Therapy in Aarhus, Denmark. The installation of the cyclotron is a key milestone for every new proton therapy center.

The cyclotron is a particle accelerator which accelerates protons to two thirds of the speed of light for clinical use. It is a core piece of equipment of Varian's ProBeam® system, which is equipping the four-room National Centre for Particle Therapy that will be situated alongside Aarhus University Hospital in Denmark's second largest city. Patient treatments are expected to start at the new facility in the second half of next year.

"The installation of the cyclotron is a major milestone in this project and gets us closer to making this advanced cancer fighting technology available to patients in Denmark," said Ole Nørrevang, chief physicist, Danish Centre for Particle Therapy. "This new center will be big step forward in cancer care in Denmark."

"We are very proud to be partnering with the National Centre for Particle Therapy on the development of this new facility," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division. "This cyclotron installation is another exciting step forward for proton therapy and the growing accessibility of this cancer fighting technology."

Varian's ProBeam system is the first to offer fully-integrated intensity modulated proton therapy (IMPT) to enable more efficient adaptive proton therapy. The Varian's pencil beam scanning technology gives clinicians the ability to deliver the dose precisely in the tumor to minimize dose to healthy tissue. When combined with cone beam computed tomography (CBCT), the ProBeam system enables advanced adaptive therapy during the course of treatment helping to make it a more precise form of proton therapy.

About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com

 

SOURCE Varian Medical Systems